3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years

Source Motley_fool

Key Points

  • The stocks listed below yield between 2.7% and 3.5%.

  • They are in different sectors of the economy and can help diversify your portfolio while also generating plenty of recurring cash flow.

  • 10 stocks we like better than AbbVie ›

Want some quality income-generating investments you can put in your portfolio for the long term, and not worry about? The stocks listed below check off those boxes and can make for ideal investments to buy and hold. Not only do they offer high yields today, but they've also been growing their payouts for decades.

AbbVie (NYSE: ABBV), Home Depot (NYSE: HD), and ExxonMobil (NYSE: XOM) can diversify your portfolio while also setting you up to generate plenty of recurring cash flow for the long term. Here's a closer look at them, and why they're among the best dividend stocks you can buy today.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

A happy person holding money in front of their computer.

Image source: Getty Images.

AbbVie

Pharma stock AbbVie pays investors a yield of around 2.9% right now, which is more than double the S&P 500 average of 1.2%. The company spun off from Abbott Laboratories back in 2013, and when including its streak as part of that business, it spans more than 50 straight years, which means AbbVie is a Dividend King.

The company's most recent increase is a 5.5% boost to its payout in light of its strong financial results. Since splitting off from Abbott Labs, AbbVie has increased its quarterly dividend payments by over 330%. AbbVie hasn't simply been boosting the dividend to keep its streak going; it has been making meaningful rate hikes for its shareholders.

Through the first nine months of the year, the company has demonstrated strong growth with sales rising by 8%, to $44.5 billion. Humira is no longer its top-selling drug, but AbbVie has been able to pivot to other drugs, with Skyrizi and Rinvoq generating a combined $18.5 billion through the first three quarters, well above Humira's current quarterly tally of $3.3 billion.

With a diverse mix of drugs treating various diseases and conditions, AbbVie is one of the most robust and safest dividend stocks you can find in the healthcare sector.

Home Depot

Home improvement giant Home Depot is another top dividend growth stock to buy and hold. While it may not have the impressive growth streak that AbbVie has going, it has been raising its dividend for 16 straight years. And since 2020, its quarterly dividend has grown by more than 50%.

It's currently yielding 2.7%, which is a solid rate for the retailer. The business is facing challenges as discretionary spending has been down amid challenging economic conditions. But what's encouraging is that the company still expects sales growth of 3% for its current fiscal year (it ends in January).

Shares of Home Depot are down 13% this year as investors worry about troubling results ahead. But the home improvement retailer should recover in the long run, as it's a top name in home repair. Spending money on repairs and maintenance around the house can be put off temporarily, but it's also an inevitability that comes with home ownership, which is why I'm confident it can bounce back from any downturn, as it has in the past.

ExxonMobil

From healthcare to retail to now oil and gas, ExxonMobil is a stock that can help balance out and diversify your portfolio. Its 3.5% yield is the highest one on this list. As a leading oil and gas producer, ExxonMobil has the strength to take on myriad challenges and still generate strong results and grow its dividend.

Its dividend has grown on an annual basis for 43 consecutive years, at an average rate of 5.8%. Despite volatility in commodity prices, for decades, the company has demonstrated some excellent financial strength. This year, there has been some volatility in its bottom line as ExxonMobil's earnings have declined by $3.7 billion, to $22.3 billion thus far. But with earnings per share of $5.16 during that stretch, that's already more than what the company pays in dividends for an entire year -- $4.12.

ExxonMobil's earnings may seem shaky and volatile, but the company can afford to handle the uncertainty and still provide investors with a growing dividend over the long term. The stock is up 8% this year, and it trades at an estimated 16 times its future earnings (based on analyst estimates), making it a good value option for income investors to buy and hold.

Should you invest $1,000 in AbbVie right now?

Before you buy stock in AbbVie, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AbbVie wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $580,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,084,986!*

Now, it’s worth noting Stock Advisor’s total average return is 1,004% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of November 24, 2025

David Jagielski, CPA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie, Abbott Laboratories, and Home Depot. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
MediaTek Shares Post Best Week Since 2002 on Google AI PartnershipMediaTek Inc. is heading for its strongest weekly performance in over two decades, fueled by growing investor optimism around the Taiwanese chipmaker's collaboration with Google on artificial intelligence technology.
Author  Mitrade
Yesterday 06: 11
MediaTek Inc. is heading for its strongest weekly performance in over two decades, fueled by growing investor optimism around the Taiwanese chipmaker's collaboration with Google on artificial intelligence technology.
placeholder
Dollar Faces Sharp Weekly Decline as Investors Shift Focus to Euro and Aussie DollarThe U.S. dollar is set for its most significant weekly drop in four months, driven by expectations of monetary easing and pressure to reduce interest rates. In contrast, the yen and Australian dollar gain traction amid shifting market dynamics.
Author  Mitrade
Yesterday 02: 37
The U.S. dollar is set for its most significant weekly drop in four months, driven by expectations of monetary easing and pressure to reduce interest rates. In contrast, the yen and Australian dollar gain traction amid shifting market dynamics.
placeholder
Robinhood Stock Surges as It Expands into Booming Prediction MarketsRobinhood is deepening its push into the rapidly growing prediction markets space, driving its stock sharply higher as investors cheer the strategic expansion.
Author  Mitrade
Nov 27, Thu
Robinhood is deepening its push into the rapidly growing prediction markets space, driving its stock sharply higher as investors cheer the strategic expansion.
placeholder
Asian Stocks Rise Amid Growing Fed Rate Cut Expectations; Yen Remains in FocusAsian markets experienced gains as expectations for a Federal Reserve rate cut rose, softening the dollar. Attention turns to the yen's potential for intervention, while China's Vanke navigates bond repayment challenges.
Author  Mitrade
Nov 27, Thu
Asian markets experienced gains as expectations for a Federal Reserve rate cut rose, softening the dollar. Attention turns to the yen's potential for intervention, while China's Vanke navigates bond repayment challenges.
placeholder
Tesla's Sales Slump Deepens as Musk Focuses on Robots and Pay PackageWhile Elon Musk has been preoccupied with Tesla's robotics division and securing his landmark $1 trillion compensation package, the automaker's core business—selling vehicles—faces a worsening outlook.
Author  Mitrade
Nov 26, Wed
While Elon Musk has been preoccupied with Tesla's robotics division and securing his landmark $1 trillion compensation package, the automaker's core business—selling vehicles—faces a worsening outlook.
goTop
quote